AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
IPO Year: 2018
Exchange: NASDAQ
Website: adapthealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2024 | $14.50 → $8.00 | Buy → Hold | Jefferies |
| 11/8/2023 | $9.50 → $6.50 | Neutral → Underperform | BofA Securities |
| 5/10/2023 | $28.00 → $11.30 | Buy → Hold | Deutsche Bank |
| 5/10/2023 | $18.00 → $11.00 | Buy → Hold | Stifel |
| 5/9/2023 | $21.00 → $12.00 | Buy → Neutral | BofA Securities |
| 3/8/2022 | $31.00 → $26.00 | Outperform | RBC Capital |
| 3/2/2022 | $32.00 → $24.00 | Outperform | SVB Leerink |
| 2/18/2022 | $35.00 → $32.00 | Outperform | SVB Leerink |
| 11/5/2021 | $30.00 → $35.00 | Outperform | SVB Leerink |
| 9/27/2021 | $30.00 | Outperform | SVB Leerink |
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously
BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously
Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously
Stifel downgraded AdaptHealth from Buy to Hold and set a new price target of $11.00 from $18.00 previously
BofA Securities downgraded AdaptHealth from Buy to Neutral and set a new price target of $12.00 from $21.00 previously
RBC Capital reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $26.00 from $31.00 previously
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $24.00 from $32.00 previously
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $32.00 from $35.00 previously
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $35.00 from $30.00 previously
SVB Leerink initiated coverage of AdaptHealth with a rating of Outperform and set a new price target of $30.00
Fastest customizable press release news feed in the world
DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments."These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, C
Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businesses Sharpens strategic focus on businesses where the Company crosses the threshold of the home to deliver clinical value to patients Increases capital flexibility for reinvestment in core businesses and debt reduction, accelerating AdaptHealth's deleveraging trajectory and strengthening its balance sheet Improves AdaptHealth's expected revenue growth profile and adjusted EBITDA margins on a go-forward basis Positions Diabetes Health with an owner whose scale and operational capabilities are matched to the demands of direct-to-patient dist
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2026 financial results before the opening of the financial markets on Tuesday, August 4, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 274-8461 (Domestic) or (203) 518-9814 (International) When prompted, reference Conference ID: AHCO2Q26 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Bank of America Global Healthcare Conference, being held in Las Vegas, on Tuesday, May 12, 2026, including a fireside chat at 9:20 a.m. PT. The RBC Global Healthcare Conference, being held in New York, on Tuesday, May 19, 2026, including a fireside chat at 3:05 p.m. ET. Webcast links will be available on the Company's website, www.adapthealth.com under "Investor Relations."
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2026. First Quarter Business Highlights Completed the largest de novo expansion in the history of the home medical equipment industry, meeting an aggressive go live schedule to become the exclusive provider to the more than 10 million members of our new strategic partner. The acceleration of the transition came with $12 million of elevated labor expense, of which the majority was variable and is ex
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2026 financial results before the opening of the financial markets on Tuesday, May 5, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO1Q26 Webcast registration: Click Here Following th
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it has closed a $1.1 billion senior secured credit facility, consisting of a $325 million Term Loan A (the "Term Loan"), a $325 million Delayed Draw Term Loan (the "Delayed Draw Facility"), and a $450 million revolving line of credit (the "Revolver") (collectively, the "Credit Facility"). The closing of the Credit Facility follows recent rating upgrades by both S&P Global Ratings and Moody's Ratings, which recognized AdaptHealth's improved financial perf
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The J.P. Morgan Global Leveraged Finance Conference, being held in Miami, on Tuesday, March 3, 2026, including a fireside chat at 11:00 a.m. ET. The Leerink Partners Global Healthcare Conference, being held in Miami, on Monday, March 9, 2026, including a fireside chat at 2:20 p.m. ET. Webcast links will be available on the Company's website, www.adapthealth.com under "Investor R
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter Business Highlights Set patient census records for Sleep Health, Respiratory Health, and Wellness at Home, and a patient retention record for Diabetes Health. Acquired a leading HME provider in Hawaii, expanding the Company's geographic footprint to its 48th State and establishing operations to support the Company's new key capitated contract. Made signif
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2025 financial results before the opening of the financial markets on Tuesday, February 24, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO4Q25 Webcast registration: Clic
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
3 - AdaptHealth Corp. (0001725255) (Issuer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
8-K/A - AdaptHealth Corp. (0001725255) (Filer)
10-Q - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
DEF 14A - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
SCHEDULE 13G - AdaptHealth Corp. (0001725255) (Subject)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
Live Leadership Updates
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B
Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of Dale Wolf as Chair of the Board of Directors, effective July 1, 2024. Mr. Wolf has served on AdaptHealth's Board since November 2019 and will assume the role from outgoing Chairman Richard Barasch. Additionally, Suzanne Foster, AdaptHealth's Chief Executive Officer, has joined the Board of Directors, effective May 20, 2024. "I am thrilled to assume the role and look forward to working alongside Suzanne and her team to leverage the momentum
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer. Ms. Foster will assume leadership of the Company from interim CEO and Chairman of the Board, Richard Barasch, on May 20, 2024. Ms. Foster will join the Company from Danaher Corporation where she served as President of Beckman Coulter Life Sciences, a global provider of biomedical technologies and laboratory instruments. Ms. Foster brings over 25 years of healthcare experience
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that its Board of Directors has named Crispin Teufel as Chief Executive Officer. Teufel is expected to assume the role on September 1, 2023. Crispin Teufel, 47, has served as the Chief Executive Officer of Lincare Holdings Inc., a leading national provider of in-home respiratory care with over 700 locations in 48 states, since July 2017. Previously, Mr. Teufel served as the Chief Financial Officer of Lincare from 2013 to 2019 and as a Finance Director for Lin
Board Has Initiated a Search for a Successor AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that Stephen Griggs will step down as Chief Executive Officer by mutual agreement with the Board of Directors, effective June 30, 2023. The Board is working with a leading executive search firm to identify a new CEO and is considering several qualified candidates. Richard Barasch, Chairman of the Board, will serve as interim CEO if a successor to Mr. Griggs is not appointed by the time of his departure. Mr. Grigg
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Greg Belinfanti was appointed to the Company's Board of Directors. Mr. Belinfanti is a Senior Managing Director of One Equity Partners and will serve as OEP's designee on the Board of Directors. Mr. Belinfanti currently sits on the boards of Restorix Health and Ernest Health, and was also formerly a board member of Simplura Health Group, Arthrocare Inc (NASDAQ:ARTC), and Celltrion Healthcare, a publicly listed company in Korea. Brad Coppens, previously app
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today the appointment of Anton Hie as Vice President, Investor Relations, a newly created position. Mr. Hie will report to Jason Clemens, AdaptHealth's Chief Financial Officer. As Vice President, Investor Relations, Mr. Hie will collaborate with AdaptHealth's senior management team on the Company's growth and competitive strategy. He will also have primary responsibility for managing AdaptHealth's communications with its public shareholders and the investment commun
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company") announced today that its Board of Directors (the "Board") has appointed Stephen Griggs as Chief Executive Officer of the Company, effective immediately. Mr. Griggs, who is also a member of the Board, joined AdaptHealth in February 2021 as Co-CEO following the Company's acquisition of AeroCare Holdings, Inc., which Mr. Griggs founded and led as President and CEO. The Company also announced that Luke McGee has resigned from his positions as Co-CEO of AdaptHealth and a member of the Board. A Special Committee of independent directors, established by the Board to oversee a thorough investigation of any connection between Mr. McG
Live finance-specific insights
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2026 financial results before the opening of the financial markets on Tuesday, August 4, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 274-8461 (Domestic) or (203) 518-9814 (International) When prompted, reference Conference ID: AHCO2Q26 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2026. First Quarter Business Highlights Completed the largest de novo expansion in the history of the home medical equipment industry, meeting an aggressive go live schedule to become the exclusive provider to the more than 10 million members of our new strategic partner. The acceleration of the transition came with $12 million of elevated labor expense, of which the majority was variable and is ex
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2026 financial results before the opening of the financial markets on Tuesday, May 5, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO1Q26 Webcast registration: Click Here Following th
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter Business Highlights Set patient census records for Sleep Health, Respiratory Health, and Wellness at Home, and a patient retention record for Diabetes Health. Acquired a leading HME provider in Hawaii, expanding the Company's geographic footprint to its 48th State and establishing operations to support the Company's new key capitated contract. Made signif
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2025 financial results before the opening of the financial markets on Tuesday, February 24, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO4Q25 Webcast registration: Clic
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2025. Third Quarter Business Highlights Signed another new capitated agreement to be the exclusive HME provider for a payor serving approximately 170,000 members, and added infrastructure to support our previously announced capitated partnership with a major national healthcare system. Advanced digital patient engagement and expanded self-service capabilities, growing registered myApp users to 271
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2025 financial results before the opening of the financial markets on Tuesday, November 4, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4849 (Domestic) or (203) 518-9848 (International) When prompted, reference Conference ID: AHCO2Q25 Webcast registration: Click Here Followi
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.0 million, a decrease of 0.7%. Net income attributable to AdaptHealth Corp. was $14.7 million compared to net income of $19.4 million. Adjusted EBITDA was $155.5 million compared to $165.3 million, a decrease of 5.9%. Cas
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2025 financial results before the opening of the financial markets on Tuesday, August 5, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-4136 (Domestic) or (203) 518-9843 (International) When prompted, reference Conference ID: AHCO2Q25 Webcast registration: Click Here Followin
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi
This live feed shows all institutional transactions in real time.
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G - AdaptHealth Corp. (0001725255) (Subject)
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)
SC 13D/A - AdaptHealth Corp. (0001725255) (Subject)